-
Mercati
-
Azioni
Sustainable finance2025 Euronext ESG Trends ReportLeggi tuttoA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indici
Access the white paperInvesting in the future of Europe with innovative indicesLeggi tuttoThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF
The European market place for ETFsEuronext ETF EuropeLeggi tuttoInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fondi
-
Obbligazioni
European Defence BondsGroupe BPCE lists the first bondLeggi tuttoFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Prodotti strutturati
-
Derivati
Where European Government Bonds Meet the FutureFixed Income derivativesLeggi tuttoTrade mini bond futures on main European government bonds
-
Commodities
- Panoramica
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Consegna e liquidazione
- Specifiche e disposizioni
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLeggi tuttoEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Documenti e risorse
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLeggi tuttoJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
BIOSYNEX
Identification
Listing sponsor / Euronext Growth Advisor
EUROLAND FINANCE
Ticker
XXXX
Codice ISIN
FR0011005933
Mercato
Euronext
Borsa
Paris
Products family
Stocks
Market organization
Alternext
ICB
Medical Supplies
Activity description
Biosynex est spécialisée dans la recherche, le développement et la fabrication de tests de diagnostic rapide sur support membranaire en médecine humaine. Biosynex est à ce jour spécialisée dans 4 domaines:
- Les marqueurs d’urgence (rupture de membranes, protection anti tétanos)
- Les maladies infectieuses (mononucléose infectieuse)
- Les pathologies tropicales (paludisme, maladie de Chagas ….)
- Les maladies auto-immunes (intolérance au gluten, thyroïdites auto-immunes,…)
La société emploie actuellement 15 personnes, dont 5 scientifiques dans le département R&D.
Indirizzo web
http://biosynex.nexenservices.com
Indirizzo web
http://biosynex.nexenservices.com
Operation
Data IPO
Lun 21/03/2011
Tipologia IPO
Public offer NYSE Alternext à Paris
Tipologia IPO
Initial Public offering
Categoria
IPO